Pure DSMO injections as blank reference cause no pain. It’s the rapamycin bolus to the tissue. As I continued my protocol, it appears my tissues became accustomed to the cellular rapamycin already in circulation, and lately, IM injections are relatively quite painless +/-
Currently this far along, there are no ongoing visible (bruising, etc) or physiological signs (gait, soreness) or symptoms related to the IM injection site re possible “tissue” damage, other than typical sting and small bump at the injection site. And lately, stinging and bump is often completely lacking.
The DSMO is stored in original dark glass bottle and blackout container. Prepared doses are frozen until taken. See other post re preparation protocol.
https://sci-hub.hkvisa.net/10.1016/s0378-5173(00)00617-7
Please suggest a high solubility, high concentration, safer solution, that allows target dose and VERY low injection dosing volume (fraction of mL).
Preferred, what is your reference? I am taking rapamycin for only one reason: longevity enhancement.
What is the rapamycin dosing/AUC that delivers our objective…translation of countless mice longevity studies where mice exposed to ever increasing doses live longer, to human longevity escapism? Are you suggesting the answer to this question?
You realize therapeutic rapamycin dosing (cancer/transplant) is a continuous high AUC dosing protocol? Trough levels (AUC proxy) are maintained for years at 5-15 ng/mL? These are not an “eliminated quickly” protocol.
Injections are one of the most commonly used methods of delivering drugs in the world. They might have less compliance than say oral, but this is not a compliance forum…this is a biohacker/longevity forum.
As you know, bioavailability of IM and IV are almost 100%.
Recent FDA approved sirolimus formulation for IV delivery:
I am just running an outside the box sortie experiment…no idea where this goes, benefits, outcome, or duration. Just sharing my n=1 and the rationale behind it, and hoping to move the needle.